jason_flowerday,_emba
2004
Jason Flowerday, EMBA, was appointed CEO of 3D Signatures Inc., in September 2016. The company offers personalized medicine through proprietary software that can analyze a patient’s chromosomal arrangement — or signature — through a blood test or tissue sample. Its technology can predict the course of disease and customize patient treatment. Previously, Jason had co-founded Orphan Canada and RxMedia Healthcare Communications, after having worked at Bayer AG and Johnson & Johnson. He continues to reside in Toronto.Â